⊕ Affiliate content · we may earn if you start a program · information verified independently

Ozempic Price Guide 2026: Costs, Coverage, and Cheaper Alternatives

Ozempic (semaglutide 0.25–2 mg) was originally approved by the FDA for type 2 diabetes, but it became one of the most talked-about medications in America after patients discovered its powerful weight loss effects. While Wegovy is the official semaglutide product for weight management, Ozempic remains widely prescribed — both for diabetes and off-label for weight loss — often with different insurance coverage rules and pricing structures. This guide covers every aspect of Ozempic pricing in 2026, from retail costs and insurance pathways to why many patients are switching to more affordable alternatives like compound semaglutide.

Ozempic Retail Price in 2026

Ozempic (semaglutide injection) is manufactured by Novo Nordisk and FDA-approved for glycemic control in adults with type 2 diabetes, as well as for reducing cardiovascular risk in adults with type 2 diabetes and established cardiovascular disease. It is available in three dose strengths: 0.25 mg, 0.5 mg, 1 mg, and 2 mg, all administered once weekly via subcutaneous injection using prefilled pens. In 2026, the wholesale acquisition cost (WAC) for Ozempic is approximately $1,029 per 28-day supply. Retail pharmacy prices vary: CVS: $1,069–$1,350 Walgreens: $1,051–$1,327 Walmart Pharmacy: $985–$1,212 Costco Pharmacy: $968–$1,189 Online/mail-order: $945–$1,149 Ozempic is generally less expensive than Wegovy at most pharmacies, reflecting its different indication (diabetes vs. weight management) and the slightly lower maximum dose (1–2 mg vs. 2.4 mg). However, prices remain high for patients paying out of pocket. The Ozempic dosing schedule involves a titration period: - 0.25 mg weekly for the first 4 weeks (starter dose) - 0.5 mg weekly for the next 4 weeks - 1 mg weekly (maintenance dose for most patients) - 2 mg weekly (maximum dose, approved in 2022) All dose strengths are priced similarly per monthly supply. The prefilled pen design eliminates the need for separate syringes and simplifies administration compared to compound semaglutide, which requires manual injection. [1]

Ozempic vs. Wegovy: Price and Access Differences

Since both Ozempic and Wegovy contain the same active ingredient (semaglutide), many patients wonder which is the better deal. Here is a detailed comparison: Active ingredient: Both are semaglutide — identical molecule Maximum dose: Ozempic maxes out at 1 mg (or 2 mg with the newer high-dose formulation), while Wegovy goes up to 2.4 mg FDA indication: Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management Off-label use: Many providers prescribe Ozempic off-label for weight loss, especially for patients whose insurance covers diabetes medications but not weight loss medications Delivery device: Both use prefilled injection pens Pricing comparison: - Ozempic retail: $945–$1,350/month - Wegovy retail: $1,149–$1,587/month - Ozempic is typically $100–$200/month cheaper than Wegovy at the same pharmacy Insurance coverage differences: This is where the distinction matters most. Because Ozempic is indicated for diabetes, it is covered by nearly all insurance plans that cover diabetes medications — including plans that explicitly exclude weight loss drugs. Some patients who are denied Wegovy coverage can obtain Ozempic if they have a qualifying diabetes or prediabetes diagnosis. However, using Ozempic specifically for weight loss without a diabetes diagnosis constitutes off-label prescribing. While legal and common, this can complicate insurance coverage. Some insurers have begun requiring proof of type 2 diabetes (elevated HbA1c) before approving Ozempic, specifically to prevent off-label weight loss prescribing. [2] If you have a legitimate type 2 diabetes or prediabetes diagnosis, Ozempic may offer better insurance access than Wegovy at a slightly lower price point. If you are seeking semaglutide purely for weight management without diabetes, Wegovy is the on-label option — or consider compound semaglutide for the best value.

Compare GLP-1 pricing

See current prices from top-rated telehealth providers. We may earn a commission. See disclosures.

Ozempic Insurance Coverage and Copays

Insurance coverage for Ozempic is generally more favorable than for Wegovy, thanks to its diabetes indication. Here is what to expect: Employer-sponsored commercial insurance: Ozempic is covered by approximately 85-90% of commercial plans for patients with a type 2 diabetes diagnosis. It is typically placed in Tier 2 or Tier 3, with copays of $25–$75 per month after deductible. Prior authorization is usually required but is approved more readily than for weight loss medications. For patients WITHOUT diabetes seeking weight loss: Coverage is much less certain. Some plans cover Ozempic for prediabetes (HbA1c 5.7-6.4%) or metabolic syndrome. Others require a documented diabetes diagnosis. An increasing number of plans have added "diagnosis verification" requirements specifically to prevent off-label Ozempic use for weight loss. Medicare Part D: Ozempic is covered by virtually all Part D plans for patients with type 2 diabetes. Copays range from $35–$85 per month after deductible, with the $2,000 annual out-of-pocket cap. Medicare does not require a prior authorization for Ozempic when prescribed for its FDA-approved indication. Medicaid: Most state Medicaid programs cover Ozempic for type 2 diabetes with minimal copay ($1–$10). Coverage for off-label weight loss use varies by state and is more restrictive. Novo Nordisk Ozempic Savings Card: - For commercially insured patients: Pay as little as $25/month (card covers up to $150 per fill, max $1,800/year) - For patients without insurance coverage: Card reduces price to approximately $550/month - Not available for Medicare or Medicaid beneficiaries How to check your coverage: 1. Call the number on your insurance card 2. Ask: "Is Ozempic (NDC 0169-6138) on my formulary?" 3. Ask: "What diagnosis codes are required for coverage?" 4. Ask: "Is prior authorization required, and what are the criteria?" [3]

Cheaper Alternatives to Ozempic

If Ozempic is not affordable or not covered for your situation, several alternatives offer the same or similar active ingredients at lower prices: 1. Compound semaglutide via telehealth ($85–$249/month) This is the best value alternative for most patients. Compound semaglutide contains the same active ingredient as Ozempic at a fraction of the cost. Providers like Mochi ($85/mo), Hims ($199/mo), and Henry Meds ($249/mo) offer compound semaglutide with medical consultation and home delivery. See our semaglutide cost guide for detailed comparisons. 2. Wegovy (if you have insurance coverage for weight loss) Wegovy offers a higher maximum dose (2.4 mg vs. Ozempic's 1–2 mg) and is the on-label option for weight management. If your insurance covers Wegovy, the Novo Nordisk savings card can reduce your copay to $0–$25/month. See our Wegovy pricing guide for details. 3. Rybelsus (oral semaglutide) Rybelsus is the oral tablet form of semaglutide, FDA-approved for type 2 diabetes. It avoids injections entirely but has lower bioavailability (~1% vs. ~89% for injection) and may be less effective for weight loss at equivalent doses. Retail price is similar to Ozempic. Some compound providers offer oral semaglutide capsules at lower prices. 4. Tirzepatide (Zepbound or compound) If you are looking for maximum weight loss and are open to a different medication, tirzepatide (dual GIP/GLP-1 agonist) has shown superior efficacy in head-to-head trials. Compound tirzepatide costs $249–$449/month. See our tirzepatide cost guide for detailed pricing. 5. Other GLP-1 medications Older GLP-1 agonists like liraglutide (Victoza/Saxenda) and dulaglutide (Trulicity) are available at lower prices, especially as some approach generic competition. However, they are generally less effective and less convenient (daily injection for liraglutide) than semaglutide. 6. Metformin + lifestyle intervention For patients with prediabetes or early type 2 diabetes, metformin ($4–$10/month at most pharmacies) combined with structured lifestyle changes can provide meaningful metabolic improvement at minimal cost, though weight loss results are modest compared to GLP-1 medications. [4]

Compare GLP-1 pricing

See current prices from top-rated telehealth providers. We may earn a commission. See disclosures.

Using Ozempic for Weight Loss: What You Need to Know

Ozempic has become synonymous with weight loss in popular culture, but it is important to understand the distinction between its FDA-approved use (type 2 diabetes) and the common off-label use for weight management: Off-label prescribing is legal and common. Physicians can prescribe any FDA-approved medication for any clinically appropriate purpose. The FDA regulates drug approval, not the practice of medicine. Many medications are prescribed off-label, and Ozempic's off-label use for weight loss is widely accepted in the medical community. Why Ozempic works for weight loss: The active ingredient (semaglutide) suppresses appetite by mimicking GLP-1 hormones, slowing gastric emptying, and signaling satiety to the brain. At the 1 mg dose, clinical data suggest weight loss of approximately 8-10% — less than Wegovy's 14.9% at 2.4 mg, but still clinically significant. Limitations of Ozempic for weight loss: - Maximum dose is 1 mg (or 2 mg with newer formulation), compared to Wegovy's 2.4 mg - The lower dose means less weight loss for most patients - Insurance may not cover off-label use - Your provider must document a clinical rationale for choosing Ozempic over Wegovy When Ozempic makes sense for weight loss: - You have type 2 diabetes or prediabetes and want a single medication for both glycemic control and weight management - Your insurance covers Ozempic for diabetes but not Wegovy for weight loss - You want to start at a lower dose to assess tolerance before committing to higher-dose Wegovy - You and your provider prefer the established safety profile of the 1 mg dose When Wegovy or compound semaglutide is better: - You do not have diabetes and want the on-label weight loss medication - You want the maximum dose (2.4 mg) for optimal weight loss - Your insurance covers weight loss medications - You prefer the compound route for cost savings The growing popularity of Ozempic for weight loss has contributed to periodic supply shortages, which the FDA has tracked on its drug shortage database. During shortage periods, the FDA permits compounding pharmacies to produce semaglutide under 503A and 503B regulations — which is partly why compound semaglutide has become so widely available. [5]

Pricing comparison — providers in this guide

Provider Price Meds Score
Henry Meds Editor's Choice $249 /mo starting
SemaTirz
9.4 Visit →
Ro Best Brand Trust $199 /mo starting
SemaTirz
9.1 Visit →
Hims Best Value $199 /mo all-in
SemaTirz
8.6 Visit →

Affiliate disclosure: GoGLP1 earns a commission from qualifying enrollments. This never affects our rankings. Reviewed 2026.

Find the best price for your GLP-1

Start with a free consultation — most providers accept insurance. See disclosures.

References

  1. [1]Novo Nordisk. Ozempic (semaglutide injection) Prescribing Information. Updated 2026.
  2. [2]Academy of Managed Care Pharmacy. GLP-1 Receptor Agonist Formulary Coverage and Off-Label Prescribing Trends. 2025.
  3. [3]Novo Nordisk. Ozempic Savings Card Program: Terms and Conditions. Accessed May 2026.
  4. [4]American Diabetes Association. Standards of Medical Care in Diabetes — Pharmacologic Approaches to Glycemic Treatment. 2026.
  5. [5]U.S. Food and Drug Administration. FDA Drug Shortages Database: Semaglutide Products. Updated 2026.
  6. [6]IQVIA Institute. Global Use of Medicines 2026: Outlook for GLP-1 Receptor Agonists and Market Dynamics.

§ FAQ — Common questions about cost

How much does Ozempic cost per month without insurance?

Without insurance, Ozempic costs $945–$1,350/month at retail pharmacies depending on the pharmacy and location. With discount programs like GoodRx, the price can be reduced to approximately $800–$1,050/month. The Novo Nordisk savings card can reduce the price further to approximately $550/month for patients without insurance coverage. For the most affordable option, compound semaglutide (same active ingredient) from telehealth providers costs $85–$249/month.

Can I get Ozempic for weight loss if I do not have diabetes?

Yes, but it will be prescribed off-label. Many providers prescribe Ozempic off-label for weight loss, and this is legal and widely accepted in medical practice. However, insurance coverage for off-label use is less certain — some plans require a documented diabetes or prediabetes diagnosis. If you want an on-label weight loss semaglutide product, Wegovy is FDA-approved specifically for that purpose. The most cost-effective option is compound semaglutide ($85–$249/month), which contains the same active ingredient regardless of indication.

Is Ozempic cheaper than Wegovy?

Yes, slightly. Ozempic typically costs $100–$200/month less than Wegovy at retail pharmacies. However, Ozempic's maximum dose (1–2 mg) is lower than Wegovy's (2.4 mg), so weight loss results may be less pronounced. With insurance, both can cost as little as $0–$25/month with manufacturer savings cards. For the cheapest semaglutide option regardless of brand, compound semaglutide from telehealth providers costs $85–$249/month. See our <a href="/cost/wegovy-price/">Wegovy pricing guide</a> for a direct comparison.

Does Medicare cover Ozempic?

Yes, Medicare Part D covers Ozempic for its FDA-approved indication (type 2 diabetes) through virtually all Part D plans. Copays range from $35–$85/month after deductible, with a $2,000 annual out-of-pocket cap on all prescription drugs combined. Coverage for off-label weight loss use is less certain and depends on the specific plan. If prescribed for type 2 diabetes, Medicare coverage of Ozempic is straightforward and typically does not require prior authorization.

What is the difference between Ozempic and compound semaglutide?

Both contain the same active ingredient (semaglutide), but they differ in manufacturing and delivery. Ozempic is manufactured by Novo Nordisk in FDA-inspected facilities and comes in prefilled injection pens. Compound semaglutide is produced by licensed compounding pharmacies and typically comes as a lyophilized powder that is reconstituted with bacteriostatic water and injected with an insulin syringe. Ozempic costs $945–$1,350/month retail; compound semaglutide costs $85–$249/month from telehealth providers. Clinical effectiveness is expected to be comparable when compound semaglutide is sourced from a reputable 503B-certified pharmacy.

HIPAA Compliant Protected health data
503B Pharmacy Licensed compounding
Board Reviewed Medical oversight
FDA Registered Regulated facilities
Editor's Choice · Henry Meds
From $249/mo starting · Free 2-day shipping
Start → Affiliate link